This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Good T Cells, Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: **Innovative Contributions of Inventor Sung-Dong Park**
Introduction
Sung-Dong Park is a notable inventor based in Seoul, South Korea. With a focus on biomedical innovations, he holds a total of three patents that highlight his contributions to the field of medical biotechnology.
Latest Patents
Sung-Dong Park's latest patents include groundbreaking research on fusion proteins designed to modulate transcription factors and treat autoimmune diseases. One of his key inventions is a fusion protein comprising the transcription modulation domain of NF-κB subunit p65 and a protein transduction domain. This novel fusion protein effectively inhibits the transcription of NF-κB and IL-2 through competitive inhibition, thereby reducing the secretion of inflammatory cytokines induced by LPS. This innovation shows promise for the prevention and treatment of diseases associated with NF-κB overactivity.
Another significant patent is focused on a composition containing a SMAD protein, aimed at the treatment of autoimmune diseases such as lupus nephritis and rheumatoid arthritis. This patent not only outlines the development of a fusion protein combining SMAD protein and an expression vector but also provides a method for its application in tackling autoimmune conditions.
Career Highlights
Sung-Dong Park works for Good T Cells, Inc., a company dedicated to advancing therapeutic solutions in the field of immunology. His expertise and inventive spirit have significantly contributed to the company's mission of developing innovative treatments for various diseases.
Collaborations
Throughout his career, Park has collaborated with esteemed colleagues, including Sang-Kyou Lee and Sang Won Lee. Their combined efforts in research and development have fostered advancements in immunotherapy and related fields.
Conclusion
Sung-Dong Park stands out as an influential figure in biomedical innovation, particularly through his work with fusion proteins that target severe health conditions. His patents not only enhance our understanding of biological processes but also pave the way for new therapeutic strategies to address pressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile